Trending Now
Plus Therapeutics Inc. (NASDAQ: PSTV) Announce Master Service Agreement For 186RNL...
Plus Therapeutics Inc. (NASDAQ: PSTV) has announced that it has attained two significant milestones as it advances towards current Good Manufacturing Practices (cGMP) production...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Aion Therapeutic Inc. (CNSX:AION) Confirms Management Appointment Amid Debentures Restructuring
Formerly known Osoyoos Cannabis Inc., Aion Therapeutic Inc. (CNSX:AION) researches, grows, and markets medical cannabis in Canada. The company has carried out a number...
MAKE IT MODERN
LATEST REVIEWS
Pot Stock Outperformance and How to Play It (GRWG, MEDH, TLRY)
The monster combination of Aphria and Tilray is a loadstone that has sparked a faith-based move by investors into the cannabis space...
MAKE IT MODERN
PERFORMANCE TRAINING
Celsion Corporation (NASDAQ:CLSN) Announces the Phase II Portion of Phase I/II OVATION 2 Study...
As a fully-integrated oncology company, Celsion Corporation (NASDAQ:CLSN) has a transformational mission. It includes improving survival and providing cures for challenging cancers. The company...
Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) Report Encouraging FDA Meeting Results For MAT9001 in SHTG
Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) has announced the End of Phase two meeting with the FDA regarding the registration pathway and development for MAT9001,...
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Announce Expanded Access For Berotralstat In HAE Patients And Findings...
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) established expanded access program (EAP) for its investigational drug berotralsat in the treatment of hereditary angioedema (HAE)patients in the US.
Berotralstat...
Onconova Therapeutics Inc. (NASDAQ:ONTX) Submits Investigational New Drug Application For ON 123300 in Advanced...
Onconova Therapeutics Inc. (NASDAQ:ONTX) has filed an Investigational New Drug application with the FDA for ON 123300, its novel, first-in-class differentiated multi-kinase inhibitor. The...
RedHill Biopharma Ltd (NASDAQ: RDHL): A Promising Leap in Crohn’s Disease Treatment
RedHill Biopharma Ltd (RDHL) has made a significant leap with its latest Phase 3 clinical trial results for RHB-104, a novel treatment...
MAKE IT MODERN
